Cinemark Holdings, Inc. 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2007. Cinemark Holdings, Inc. is a leading motion picture exhibitor with operations in the U.S., Canada, and various Latin American countries. The period reflects the full impact of the October 2006 acquisition of Century Theatres, Inc., and the company's Initial Public Offering (IPO) completed in April 2007.
Key Financial Metrics (Nine Months Ended Sept 30, 2007)
| Metric | 2007 (9 Months) | 2006 (9 Months) |
|---|---|---|
| Total Revenues | $1,289.6 million | $829.1 million |
| Net Income | $142.7 million | $21.2 million |
| Operating Income | $99.6 million | $98.2 million |
| Adjusted EBITDA | $293.1 million | $180.3 million |
| Cash from Operations | $204.1 million | $75.0 million |
| Cash and Equivalents (End Period) | $333.1 million | $142.2 million |
| Total Debt (Long-term + Current) | $1,534.6 million | $1,911.7 million |
Note: Net Income for the nine months ended Sept 30, 2007, includes significant non-operating gains (see Material Changes).
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 55.5% year-over-year, driven by a 28.5% increase in attendance and a 26.5% increase in average ticket prices. The addition of 77 Century Theatres contributed significantly to volume.
- Non-Operating Gains: Net income was heavily influenced by a $210.8 million gain from the sale of a portion of the company's investment in National CineMedia (NCM) and a $9.2 million gain from the sale of its Fandango investment.
- Impairment Charges: The company recorded $60.4 million in impairment charges for long-lived assets, primarily consisting of $46.7 million in goodwill impairment. This was triggered by the NCM transaction, which reduced future contractual payments from NCM, affecting the valuation of certain theatre assets.
- Debt Reduction: Total debt decreased by approximately $377 million. The company used proceeds from the NCM transaction and its IPO to repurchase approximately $332 million of 9% senior subordinated notes and $47 million of 9 3/4% senior discount notes.
- Operating Costs: Theatre operating costs rose to $952.0 million (73.8% of revenue) from $609.9 million (73.6% of revenue), consistent with the revenue increase and the addition of new theatres.
Guidance, Outlook, and Risks
- Capital Expenditures: The company estimates remaining capital expenditures of approximately $100 million for 230 domestic screens and $16 million for 36 international screens committed as of September 30, 2007.
- Dividends: A quarterly dividend policy was initiated in August 2007. A dividend of $0.18 per share for the third quarter was declared on November 9, 2007.
- Debt Management: The company intends to use remaining IPO proceeds to repurchase senior discount notes or repay term loan debt. It has entered into interest rate swaps to hedge $500 million of variable rate debt.
- Risks: Key risks include the seasonality of film releases, dependence on blockbuster performance, foreign currency exchange fluctuations (particularly in Brazil and Mexico), and the impact of the NCM agreement modification on future advertising revenue.
Investor Verification Checklist
- Quality of Earnings: Verify the sustainability of net income by excluding the $220 million in one-time gains from NCM and Fandango transactions.
- Goodwill Impairment: Review the specific theatres impacted by the $46.7 million goodwill impairment to assess future cash flow projections.
- Debt Covenants: Confirm compliance with the new senior secured credit facility covenants, particularly regarding leverage ratios and dividend restrictions.
- NCM Revenue Model: Analyze the long-term impact of the amended Exhibitor Services Agreement with NCM, which shifted revenue from a percentage of NCM's revenue to a fixed theatre access fee.
- Foreign Currency Exposure: Assess the impact of exchange rate fluctuations on the valuation of international assets, specifically in Brazil and Mexico.